Related Experiment Videos
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis
Raghavakaimal Sreekumar1, Barbara Rosado, Deborah Rasmussen
1Division of Gastroenterology and Hepatology, Mayo Foundation, Rochester, MN 55905, USA.
Hepatology (Baltimore, Md.)
|June 28, 2003
Summary
This study reveals unique gene expression patterns in nonalcoholic steatohepatitis (NASH), identifying transcriptional changes linked to mitochondrial dysfunction and insulin resistance in progressive liver disease.
Area of Science:
- Hepatology
- Molecular Biology
- Genomics
Background:
- Nonalcoholic steatohepatitis (NASH) pathophysiology is poorly understood.
- Insulin resistance and mitochondrial dysfunction are key features of NASH.
- Transcriptional changes may underlie these pathophysiologic hallmarks.
Purpose of the Study:
- To investigate the transcriptional basis of insulin resistance and mitochondrial dysfunction in NASH.
- To compare hepatic gene expression in cirrhotic NASH patients with other cirrhosis etiologies and healthy controls.
Main Methods:
- High-density synthetic oligonucleotide microarray analysis (Hu6800 GeneChip) was used.
- Hepatic gene expression (mRNA) was measured in liver biopsy specimens.
- Differential gene expression was defined as >2-fold change compared to control groups.
Main Results:
- Sixteen genes were uniquely differentially expressed in cirrhotic NASH.
- Twelve genes, including those vital for mitochondrial function (e.g., superoxide dismutase, catalase), were underexpressed.
- Genes linked to inflammation and insulin resistance (e.g., complement C3) were overexpressed.
Conclusions:
- Evidence suggests a transcriptional basis for impaired mitochondrial function and diminished insulin sensitivity in progressive NASH.
- Specific underexpressed genes indicate reduced capacity to handle reactive oxygen species.
- Overexpressed genes suggest an inflammatory component contributing to insulin resistance.